Advancing global antibiotic research, development and access
The global antibiotic crisis is causing a decline in private investment in research and development, leading to a shortage of antibiotics and inequitable access. Public and philanthropic funding is increasingly being used to support antibiotic R&D through nonprofit partnerships like CARB-X and GARDP. The urgency and commitment of world leaders are needed to fully support the antibiotic R&D ecosystem, incentivizing all sectors to conduct public health-driven R&D and make effective antibiotics accessible to all.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!